@article{WOS:000673531000001,
 abstract = {In children with cancer, the heterogeneity in ototoxicity occurrence
after similar treatment suggests a role for genetic susceptibility.
Using a genome-wide association study (GWAS) approach, we identified a
genetic variant in TCERG1L (rs893507) to be associated with hearing loss
in 390 non-cranial irradiated, cisplatin-treated children with cancer.
These results were replicated in two independent, similarly treated
cohorts (n = 192 and 188, respectively) (combined cohort: P= 5.3 x
10(-10), OR 3.11, 95% CI 2.2-4.5). Modulating TCERG1L expression in
cultured human cells revealed significantly altered cellular responses
to cisplatin-induced cytokine secretion and toxicity. These results
contribute to insights into the genetic and pathophysiological basis of
cisplatin-induced ototoxicity.},
 address = {HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY},
 affiliation = {Meijer, AJM (Corresponding Author), Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.
Meijer, A. J. M.; Diepstraten, F. A.; Clemens, E.; de Vries, A. C. H.; van Grotel, M.; Vermeij, W. P.; Ozinga, R. A.; van Dulmen-den Broeder, E.; Tissing, W. J. E.; van der Kooi, A. L. F.; Kremer, L. C. M.; Pluijm, S. M. F.; van der Pal, H. J. H.; Neggers, S. J. C. M. M.; van den Heuvel-Eibrink, M. M., Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.
Langer, T., Univ Hosp Children & Adolescents, Dept Pediat Oncol & Hematol, Lubeck, Germany.
Broer, L.; Uitterlinden, A. G.; Neggers, S. J. C. M. M., Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.
Domingo, I. K.; Bhavsar, A. P., Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.
Clemens, E.; de Vries, A. C. H.; van den Heuvel-Eibrink, M. M., Erasmus MC, Dept Pediat Oncol, Sophia Childrens Hosp, Rotterdam, Netherlands.
Vermeij, W. P.; Ozinga, R. A., Oncode Inst, Utrecht, Netherlands.
Binder, H.; Grabow, D.; Kaatsch, P.; Kaiser, M.; Spix, C., Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, German Childhood Canc Registry, Mainz, Germany.
Binder, H., Univ Freiburg, Inst Med Biometry & Stat, Fac Med, Freiburg, Germany.
Binder, H., Univ Freiburg, Med Ctr, Freiburg, Germany.
Byrne, J., Boyne Res Inst, Drogheda, Ireland.
van Dulmen-den Broeder, E., Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands.
Garre, M. L., IRCCS Ist Giannina Gaslini, Dept Neurooncol, Genoa, Italy.
Kenborg, L.; Winther, J. F., Danish Canc Soc Res Ctr, Childhood Canc Res Grp, Copenhagen, Denmark.
Winther, J. F., Aarhus Univ, Fac Hlth, Dept Clin Med, Aarhus, Denmark.
Winther, J. F., Univ Hosp, Aarhus, Denmark.
Rechnitzer, C., Copenhagen Univ Hosp, Dept Pediat & Adolescent Med, Rigshospitalet, Copenhagen, Denmark.
Hasle, H., Aarhus Univ Hosp, Dept Pediat, Aarhus, Denmark.
Kepak, T.; Kepakova, K., Univ Hosp Brno, Brno, Czech Republic.
Kepak, T.; Kepakova, K., Int Clin Res Ctr FNUSA ICRC, Brno, Czech Republic.
Tissing, W. J. E., Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Oncol, Groningen, Netherlands.
van der Kooi, A. L. F., Erasmus MC, Dept Obstet & Gynecol, Sophia Childrens Hosp, Rotterdam, Netherlands.
Kremer, L. C. M.; van der Pal, H. J. H., Acad Med Ctr Amsterdam, Dept Pediat Oncol, Amsterdam, Netherlands.
Kruseova, J., Motol Univ Hosp Prague, Dept Children Hematooncol, Prague, Czech Republic.
Kuehni, C. E., Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
Kuehni, C. E., Univ Bern, Univ Childrens Hosp Bern, Pediat Hematol & Oncol, Bern, Switzerland.
Parfitt, R.; Tillmanns, A.; Deuster, D.; Matulat, P.; Am Zehnhoff-Dinnesen, A. G., Westphalian Wilhelm Univ, Univ Hosp Munster, Dept Phoniatr & Pedaudiol, Munster, Germany.
Calaminus, G., Univ Childrens Hosp Muenster, Pediat Hematol & Oncol, Munster, Germany.
Hoetink, A. E., Univ Utrecht Hosp, Dept Otorhinolaryngol Head & Neck Surg, Utrecht, Netherlands.
Elsner, S., Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany.
Gebauer, J., Univ Hosp Schleswig Holstein, Dept Internal Med, Campus Lubeck, Lubeck, Germany.
Haupt, R., IRCCS Ist Giannina Gaslini, Epidemiol & Biostat Unit, Genoa, Italy.
Haupt, R., IRCCS Ist Giannina Gaslini, DOPO Clin, Genoa, Italy.
Lackner, H., Med Univ Graz, Dept Pediat & Adolescent Med, Graz, Austria.
Blattmann, C., Olga Hosp, Stuttgart Canc Ctr, Dept Pediat Oncol Hematol Immunol, Stuttgart, Germany.
Rassekh, S. R.; Wright, G. E. B.; Drogemoller, B. I.; Ross, C. J. D., BC Childrens Hosp Res Inst, Vancouver, BC, Canada.
Rassekh, S. R.; Wright, G. E. B.; Carleton, B. C., Univ British Columbia, Dept Pediat, Div Translat Therapeut, Vancouver, BC, Canada.
Brooks, B., BC Childrens Hosp, Audiol & Speech Pathol Dept, Vancouver, BC, Canada.
Nagtegaal, A. P., Erasmus MC, Dept Otorhinolaryngol, Rotterdam, Netherlands.
Drogemoller, B. I.; Ross, C. J. D.; Carleton, B. C., Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.
Bhavsar, A. P., Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
Zolk, O., Brandenburg Med Sch, Inst Clin Pharmacol, Rudersdorf, Germany.},
 affiliations = {Erasmus University Rotterdam; Erasmus MC; University of Alberta; Erasmus
University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's
Hospital; Johannes Gutenberg University of Mainz; University of
Freiburg; University of Freiburg; Vrije Universiteit Amsterdam; VU
UNIVERSITY MEDICAL CENTER; University of Genoa; IRCCS Istituto Giannina
Gaslini; Danish Cancer Society; Aarhus University; Aarhus University;
University of Copenhagen; Aarhus University; University Hospital Brno;
St Anne's University Hospital Brno (FNUSA-ICRC); University of
Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia
Children's Hospital; University of Amsterdam; Academic Medical Center
Amsterdam; Motol University Hospital; University of Bern; University of
Bern; University Hospital of Bern; University of Munster; University of
Munster; Utrecht University; Utrecht University Medical Center;
University of Lubeck; University of Kiel; Schleswig Holstein University
Hospital; University of Genoa; IRCCS Istituto Giannina Gaslini;
University of Genoa; IRCCS Istituto Giannina Gaslini; Medical University
of Graz; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart;
University of British Columbia; BC Childrens Hospital; University of
British Columbia; Erasmus University Rotterdam; Erasmus MC; University
of British Columbia; University of Alberta},
 article-number = {64},
 author = {Meijer, A. J. M. and Diepstraten, F. A. and Langer, T. and Broer, L. and
Domingo, I. K. and Clemens, E. and Uitterlinden, A. G. and de Vries, A.
C. H. and van Grotel, M. and Vermeij, W. P. and Ozinga, R. A. and
Binder, H. and Byrne, J. and van Dulmen-den Broeder, E. and Garre, M. L.
and Grabow, D. and Kaatsch, P. and Kaiser, M. and Kenborg, L. and
Winther, J. F. and Rechnitzer, C. and Hasle, H. and Kepak, T. and
Kepakova, K. and Tissing, W. J. E. and van der Kooi, A. L. F. and
Kremer, L. C. M. and Kruseova, J. and Pluijm, S. M. F. and Kuehni, C. E.
and van der Pal, H. J. H. and Parfitt, R. and Spix, C. and Tillmanns, A.
and Deuster, D. and Matulat, P. and Calaminus, G. and Hoetink, A. E. and
Elsner, S. and Gebauer, J. and Haupt, R. and Lackner, H. and Blattmann,
C. and Neggers, S. J. C. M. M. and Rassekh, S. R. and Wright, G. E. B.
and Brooks, B. and Nagtegaal, A. P. and Drogemoller, B. I. and Ross, C.
J. D. and Bhavsar, A. P. and Am Zehnhoff-Dinnesen, A. G. and Carleton,
B. C. and Zolk, O. and van den Heuvel-Eibrink, M. M. and PanCareLIFE
Consortium and CPNDS Consortium},
 author-email = {a.j.m.meijer-16@prinsesmaximacentrum.nl},
 da = {2022-12-11},
 doc-delivery-number = {TJ5OP},
 doi = {10.1038/s41698-021-00178-z},
 eissn = {2397-768X},
 funding-acknowledgement = {European Union's Seventh Framework Program for research, technological
development and demonstration [602030]; Stichting Gaby Olthuis Fonds,
the Netherlands [2020-003]; Canadian Institutes of Health Research
[PJT-153145, MY2-155361]; (Tier 2) Canada Research Chair in Functional
Genomic Medicine [231622]; Stollery Children's Hospital Foundation
through the Women and Children's Health Research Institute; Canada
Research Chairs Program; Oncode; University of Alberta Li Ka Shing
Institute of Virology; University of Alberta Faculty of Medicine
Dentistry},
 funding-text = {We would like to thank all childhood cancer patients and their families
for their contribution to this study. PanCareLIFE (PCL) is a
collaborative project in the 7th Framework Program of the European
Union. PCL partners for this project are University Medical Center
Mainz, Germany (P.K., D.G.), Boyne Research Institute, Drogheda, Ireland
(J.B., H. Campbell), Pintail Ltd., Dublin, Ireland (Mr. C. Clissmann,
Dr. K. O'Brien), Amsterdam University Medical Centers, University of
Amsterdam, Netherlands (L.C.M.K.), University of Lubeck, Germany (T.L.),
Amsterdam University Medical Centers, VU Medical Center, Netherlands
(Dr. E. van Dulmen-den Broeder, M.H. van den Berg), Erasmus Medical
Center Rotterdam, Netherlands (M.M.H.E.), Charite Hospital Berlin,
Germany (Professor A. Borgmann-Staudt, Mr. R. Schilling), University of
Munster, Germany (A.G.Z.D.), University of Bern, Switzerland (C.E.K.),
IRCCS Istituto Giannina Gaslini, Genova, Italy (R.H., Dr. F. Bagnasco),
University Hospital Brno, Czech Republic (T.K.), University Hospital
Saint Etienne, France (Dr. C. Berger, Dr. L. Casagranda), Danish Cancer
Society, Copenhagen, Denmark (J.F.W.), Motol University Hospital,
Prague, Czech Republic (J.K.), and University Hospital Bonn, Germany
(G.C., K.B.). Discovery cohort data in PCL were provided by: Erasmus
Medical Center, Netherlands (M.M.H.E.), Princess Maxima Center for
Pediatric Oncology, Netherlands (M.M.H.E.), University Medical Center
Groningen, Netherlands (W.J.E.T.), Amsterdam University Medical Centers,
University of Amsterdam, Netherlands (L.C.M.K.), University of Munster,
Germany (A.G.Z.D., Professor U. Dirksen), University of Bern,
Switzerland (C.E.K.), IRCCS Istituto Giannina Gaslini, Genova, Italy
(R.H., M.L.G.), The University Hospital Brno, Czech Republic (T.K.),
Danish Cancer Society, Copenhagen, Denmark (J.F.W.), Motol University
Hospital, Prague, Czech Republic (J.K.), Medical University of Graz,
Austria (H.L.), Ulm University, Germany (Professor H. Cario, O.Z.),
University of Lubeck, Germany (T.L.), Klinikum Stuttgart, Olgahospital,
Germany (Professor S. Bielack), and University Hospital Bonn, Germany
(G.C.). Replication cohort 1 data were provided by Canadian
Pharmacogenomics Network for Drug Safety (CPNDS) Consortium (Vancouver,
British Columbia Children's Hospital, B.C.C., C.J.D.R., S.R.R.;
Edmonton, University of Alberta, A.P.B., D.E.; Calgary, Alberta
Children's Hospital, G Guilcher; Winnipeg Health Sciences Centre, J.M.,
G.'t.J, G.C.; London Health Sciences Centre, M.R.; Toronto, Hospital for
Sick Children: S.I., P.N.; Ottawa, Children's Hospital of Eastern
Ontario, R.V., D.J.; Montreal, CHU Sainte-Justine, J.-F.B., D.L.;
Montreal Children's Hospital, N.J.; Halifax, IWK Health Centre, K.G.,
K.K.). Replication cohort 2 data were provided by Ulm University,
Germany (O.Z.). Age-related hearing loss data were provided by the
Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE)
consortium, Erasmus Medical Center, Netherlands (A.P.N.). Functional
validation experiments were performed at the Department of Medical
Microbiology and Immunology, University of Alberta, Canada (A.P.B.), and
at the Princess Maxima Center for Pediatric Oncology, Netherlands
(W.P.V.). This work was supported by the PanCareLIFE project that has
received funding from the European Union's Seventh Framework Program for
research, technological development and demonstration under grant
agreement no 602030. AM is supported by Stichting Gaby Olthuis Fonds,
the Netherlands, under Grant number 2020-003.; Functional studies have
been supported by funding from the Canadian Institutes of Health
Research; PJT-153145 and MY2-155361 to A.B., C.R., and B.C. and
recruitment funding from the University of Alberta Li Ka Shing Institute
of Virology and Faculty of Medicine & Dentistry to AB, and Oncode to WV
and RO. AB holds a (Tier 2) Canada Research Chair (231622) in Functional
Genomic Medicine and this research was undertaken, in part, thanks to
funding from the Canada Research Chairs Program. This research has also
been funded by the generous support of the Stollery Children's Hospital
Foundation through the Women and Children's Health Research Institute to
AB.},
 journal = {NPJ PRECISION ONCOLOGY},
 journal-iso = {npj Precis. Oncol.},
 keywords-plus = {DNA HYPERMETHYLATION; OTOTOXICITY; CHILDREN; TOXICITY; CELLS; PANEL},
 language = {English},
 month = {JUL 14},
 number = {1},
 number-of-cited-references = {35},
 oa = {Green Published, gold},
 orcid-numbers = {Kenborg, Line/0000-0002-3584-6570
Rassekh, Shahrad Rod/0000-0001-8005-2641
Hoetink, Alexander/0000-0002-7417-5546
Domingo, Ivan/0000-0003-3901-4103
Meijer, Annelot/0000-0003-1631-0006
Diepstraten, Robin/0000-0002-2507-1820
Vermeij, Wilbert/0000-0002-9690-1385
Kremer, Leontien/0000-0001-7422-3248
Broer, Linda/0000-0003-0011-123X
Nagtegaal, Andries Paul/0000-0001-8128-7178},
 publisher = {NATURE RESEARCH},
 research-areas = {Oncology},
 researcherid-numbers = {Kenborg, Line/T-4122-2018
Rassekh, Shahrad Rod/G-5301-2010
},
 times-cited = {1},
 title = {TCERG1L allelic variation is associated with cisplatin-induced hearing
loss in childhood cancer, a PanCareLIFE study},
 type = {Article},
 unique-id = {WOS:000673531000001},
 usage-count-last-180-days = {0},
 usage-count-since-2013 = {9},
 volume = {5},
 web-of-science-categories = {Oncology},
 web-of-science-index = {Science Citation Index Expanded (SCI-EXPANDED)},
 year = {2021}
}

